Tetrapeptide · Fact sheet

Epitalon

Also known as Epithalon · AEDG

Epitalon has changed telomerase activity and telomere length in cell experiments. Those findings do not show that it extends human life, reverses aging, or improves sleep, and it is not FDA approved.

Not FDA approvedMostly animal or lab research

What is Epitalon?

Epitalon is a synthetic four-amino-acid peptide. It should not be treated as interchangeable with epithalamin, a tissue-derived preparation used in some older reports.

Telomeres are chromosome-end structures; changing them in cultured cells is different from improving health in a person.

Benefits & claims

Longevity, sleep regularity, and a younger biological age are the main claims readers encounter. Cell-lifespan findings cannot answer those questions on their own.

What the evidence supports

  • A 2003 experiment reported telomerase activation and telomere extension in cultured fibroblasts.
  • More recent cell work explored different mechanisms in normal and cancer cell lines; it does not demonstrate a human longevity benefit.
Research areas
  • Telomerase activity
  • Telomere biology
  • Cellular aging

Dosage & frequency

No established human regimen

Epitalon research does not establish a human longevity treatment dose or repeat-cycle schedule. Cell telomerase findings are not a dosing guide.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Epitalon is a defined short peptide; heterogeneous epithalamin preparations are different evidence.

Interactions & precautions

  • A validated human drug-interaction profile is not established; cell telomerase experiments do not answer combination safety.

What is still unresolved

  • A validated human formulation, regimen, clinical benefit, and long-term safety profile remain unresolved.

Side effects & risks

  • FDA flags immune-response and impurity concerns and missing route-specific safety information.
  • Cell experiments cannot establish long-term cancer safety or quantify adverse effects in people.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Mostly animal or lab research

The cited telomere experiments used cultured human cells, not clinical treatment of people. A 2025 cell-line paper also has a published correction linked in the source record.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Energy: reported experiences

Negative account · personal report

Sleepless nights and daytime exhaustion

An author with pre-existing fragmented sleep described two sleepless nights and feeling exhausted after trying Epitalon.

Reported use in this account

Product
Product described as Epitalon
Amount
500 mcg on each reported night
Frequency
On two consecutive nights
Route
Not specified clearly
Duration
Two nights

The short account cannot separate the compound from ongoing insomnia or verify its contents.

Read the original account
Mixed account · personal report

More daytime energy, but early waking

Another author described falling asleep, then waking after a few hours and being unable to return to sleep, despite feeling energetic and in a good mood during the day.

Reported use in this account

Product
Product described as Epitalon
Amount
1 mg, 5 mg and 10 mg were reported at different times
Frequency
Not specified clearly
Route
Not specified clearly
Duration
Ten days at 10 mg; approximately a week at 1 mg were described

This subjective pattern does not establish improved sleep quality, a circadian mechanism or a long-term benefit.

Read the original account

Approval status

Epitalon has no FDA-approved product. Laboratory telomere studies and older reports on related preparations do not document an approved anti-aging treatment.

No established FDA drug approval path

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Effects on human lifespan or age-related disease
  • Reliable sleep outcomes
  • Long-term effects on cell growth and cancer risk

Summary

Epitalon is an experimental aging research topic, with a large gap between cell findings and demonstrated human outcomes.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. fdaFDA: safety concerns for selected bulk substances

    Ingredient-specific safety findings; compounding review is not drug approval.

  2. pubmedEpithalon and telomerase in cultured fibroblasts

    Cell experiment, not a human longevity trial.

  3. pubmedEpitalon and telomere length in cell lines

    Normal and cancer cell experiments; see the linked published correction.

  4. pubmedCorrection to the 2025 epitalon cell study

    Correction replacing incorrectly published figures 1–3; the original article has been corrected.

How we assess sources · Suggest a correction